Shopping Cart 0
Cart Subtotal
USD 0

Oncolytics Biotech Inc (ONC) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company's lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of lung, ovarian, colorectal, pancreatic, prostate, breast, head and neck cancers. Reolysin is also undergoing various other clinical trials to determine its use in other types of cancer, such as for squamous cell carcinoma, metastatic colorectal cancer, metastatic melanoma trial, and non-small cell lung cancer. The company and its partners conduct clinical trials across Canada and the US. Oncolytics is headquartered in Calgary, Alberta, Canada.

Oncolytics Biotech Inc (ONC)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Oncolytics Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Oncolytics Biotech Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Oncolytics Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Oncolytics Biotech Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Oncolytics Biotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Oncolytics Biotech Inc, Medical Equipment, Deal Details 10

Private Equity 10

Oncolytics Biotech to Raise up to USD26 Million in Private Placement of Shares 10

Equity Offering 11

Oncolytics Biotech Raises USD8.9 Million in Public Offering of Share 11

Oncolytics Biotech Raises USD8.5 Million in Public Offering of Units 12

Oncolytics Biotech Completes First Tranche Of Private Placement Of Shares For USD 1 Million 14

Oncolytics Biotech Completes Public Offering Of Common Stock For USD 32 Million 15

Oncolytics Biotech Completes Private Placement Of Shares For USD 21 Million 16

Oncolytics Biotech Inc-Key Competitors 18

Oncolytics Biotech Inc-Key Employees 19

Oncolytics Biotech Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Strategy And Business Planning 21

Jun 27, 2017: Oncolytics Biotech Opens U.S. Based Office in San Diego 21

Financial Announcements 22

Aug 03, 2018: Oncolytics Biotech reports 2018 second quarter results 22

May 11, 2018: Oncolytics Biotech Reports 2018 First Quarter Results 23

Mar 09, 2018: Oncolytics Biotech Announces 2017 Year End Results 24

Aug 03, 2017: Oncolytics Biotech Announces 2017 Second Quarter Results 26

May 05, 2017: Oncolytics Biotech Announces 2017 First Quarter Results 27

Mar 10, 2017: Oncolytics Biotech Announces 2016 Year-End Results 28

Corporate Communications 29

Apr 17, 2018: Oncolytics Biotech Announces Resignation Of Andres Gutierrez As Chief Medical Officer 29

Jan 25, 2018: Oncolytics Biotech Named to the 2018 OTCQX Best 50 30

Jun 29, 2017: Oncolytics Biotech Appoints Andrew de Guttadauro, President of Oncolytics Biotech 31

Jan 19, 2017: Oncolytics Biotech Appoints Dr. Matt Coffey to the Role of President and CEO 32

Legal and Regulatory 33

Jun 01, 2018: Oncolytics Biotech Announces Listing on Nasdaq Capital Market 33

May 29, 2018: Oncolytics Biotech Announces New OTCQX Ticker Symbol 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Oncolytics Biotech Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Oncolytics Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Oncolytics Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Oncolytics Biotech Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Oncolytics Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Oncolytics Biotech Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Oncolytics Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Oncolytics Biotech Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Oncolytics Biotech Inc, Medical Equipment, Key Facts, 2017 2

Oncolytics Biotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Oncolytics Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Oncolytics Biotech Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Oncolytics Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Oncolytics Biotech Inc, Deals By Market, 2012 to YTD 2018 8

Oncolytics Biotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Oncolytics Biotech to Raise up to USD26 Million in Private Placement of Shares 10

Oncolytics Biotech Raises USD8.9 Million in Public Offering of Share 11

Oncolytics Biotech Raises USD8.5 Million in Public Offering of Units 12

Oncolytics Biotech Completes First Tranche Of Private Placement Of Shares For USD 1 Million 14

Oncolytics Biotech Completes Public Offering Of Common Stock For USD 32 Million 15

Oncolytics Biotech Completes Private Placement Of Shares For USD 21 Million 16

Oncolytics Biotech Inc, Key Competitors 18

Oncolytics Biotech Inc, Key Employees 19

Oncolytics Biotech Inc, Other Locations 20

Oncolytics Biotech Inc, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Oncolytics Biotech Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.